Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
- PMID: 36596315
- PMCID: PMC9804970
- DOI: 10.1016/j.jinf.2022.12.027
Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
Keywords: COVID-19; Critically ill patients; Intensive care; Outcomes; Remdesivir.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Leisman Daniel E., Lukas Ronner, Rachel Pinotti, Taylor Matthew D., Pratik Sinha, Calfee Carolyn S., et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8(12):1233–1244. doi: 10.1016/S2213-2600(20)30404-5. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical